DOCSLIB.ORG

Annual Report 2016

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2016 Please note: this PDF contains only the pages highlighted in the list of contents below. The contents of this file are qualified in their entirety by reference to the printed version of the Philips Annual Report 2016. The information in this PDF has been derived from the audited financial statements 2016 of Koninklijke Philips N.V. Ernst & Young Accountants has issued unqualified auditors’ reports on these financial statements. Annual Report 2016 Analyst selection A focused leader in health technology Contents Grey text indicates parts not included in this selection from the Philips Annual Report 2016. 1 Message from the CEO 4 2 Group performance 7 2.1 Financial performance 7 2.2 Social performance - 2.3 Environmental performance - 2.4 Proposed distribution to shareholders 18 3 Segment performance 19 3.1 Personal Health businesses 21 3.2 Diagnosis & Treatment businesses 24 3.3 Connected Care & Health Informatics businesses 28 3.4 HealthTech Other 32 3.5 Lighting 36 3.6 Legacy Items 39 4 Reconciliation of non-GAAP information 40 5 Risk management 44 5.1 Our approach to risk management 44 5.2 Risk categories and factors 48 5.3 Strategic risks 48 5.4 Operational risks 50 5.5 Compliance risks 52 5.6 Financial risks 53 6 Management 55 7 Supervisory Board 56 8 Supervisory Board report - 9 Corporate governance - 2 This is the analyst selection from the Annual Report 2016 10 Group financial statements 57 11 Company financial statements 121 10.1 Management’s report on internal control - 11.1 Statements of income 122 10.2 Report of the independent auditor - 11.2 Balance sheets before appropriation of results 123 10.3 Independent auditors’ report on internal control - 11.3 Statement of changes in equity 124 over financial reporting 11.4 Notes 125 10.4 Consolidated statements of income 57 10.5 Consolidated statements of comprehensive 58 A Sales 125 income B Other business income 125 10.6 Consolidated balance sheets 59 C Sales and costs by nature 125 10.7 Consolidated statements of cash flows 61 D Financial income and expense 125 10.8 Consolidated statements of changes in equity 62 E Income tax 125 10.9 Notes 63 F Employees 125 G Intangible assets 125 General, segment and main countries H Financial fixed assets 125 information I Other financial assets 126 1 Significant accounting policies 63 J Receivables 126 2 Information by segment and main country 78 K Shareholders’ equity 126 3 Discontinued operations and other assets 80 L Debt 129 classified as held for sale M Other current liabilities 129 4 Acquisitions and divestments 81 N Contractual obligations and contingent 129 5 Interests in entities 82 liabilities not appearing in the balance sheet O Subsequent events 130 Notes related to the income statement P Appropriation of profits and profit 130 6 Income from operations 84 distributions 7 Financial income and expenses 85 8 Income taxes 85 11.5 Independent auditor’s report - 9 Earnings per share 86 12 Sustainability statements - Notes related to the balance sheet 10 Property, plant and equipment 87 13 Five-year overview 131 11 Goodwill 88 12 Intangible assets excluding goodwill 90 14 Investor Relations 134 13 Other financial assets 91 14.1 Key financials and dividend 134 14 Other assets 91 14.2 Share information 136 15 Inventories 92 14.3 Philips’ rating 138 16 Receivables 92 14.4 Performance in relation to market indices 138 17 Equity 92 14.5 Financial calendar 141 18 Debt 95 14.6 Investor contact 141 19 Provisions 97 20 Post-employment benefits 97 15 Definitions and abbreviations 143 21 Accrued liabilities 102 22 Other liabilities 102 16 Forward-looking statements and other 145 information Notes related to the cash flow statement 23 Cash flow statement supplementary 102 information 24 Contractual obligations 103 Other notes 25 Contingent assets and liabilities 104 26 Related-party transactions 106 27 Share-based compensation 107 28 Information on remuneration 110 29 Fair value of financial assets and liabilities 113 30 Details of treasury / other financial risks 116 31 Subsequent events 120 This is the analyst selection from the Annual Report 2016 3 Message from the CEO 1 1 Message from the CEO “ We have transformed Philips into a focused leader in health technology, delivering innovation to help people manage their health and to support care providers in delivering care effectively.” Frans van Houten, CEO Royal Philips Dear Stakeholder, In 2016, our products and services improved the lives of 2.1 I am very excited about the future of Philips as a billion people around the world. We also launched our new focused leader in health technology, innovating new five-year ‘Healthy people, sustainable planet’ program, approaches to global health challenges. 2016 was a supporting the aim of improving the lives of 3 billion people defining year for our company as we celebrated our per year by 2025 and becoming carbon-neutral in our 125th year as an innovation company and continued to operations by 2020. And at the World Economic Forum in advance our transformation. Our strategic focus is January 2017 the Chairman of our Supervisory Board and I already delivering results. signed the Compact for Responsive and Responsible Leadership, an initiative to promote and align the long-term We have successfully integrated our Volcano acquisition, sustainability of corporations and the long-term goals of achieving multiple quarters of double-digit growth, society, with an inclusive approach for all stakeholders. significant growth synergies with our image-guided therapy business, and cost synergies well beyond our Our overall 2016 performance gives me great confidence for original plans. the future as we build upon outstanding positions in the hospital and the home, expand our solutions capability and We separated the Lighting business, executing a complex continue to deliver on the promise of digitization and smart, project on time and below budget. In May we successfully connected care. listed Philips Lighting on the Amsterdam Euronext stock exchange, giving it the opportunity to build on its Transforming the delivery of care leadership position in the exciting Lighting industry. In its As consumers take a more active role in managing their first year as a stand-alone company, Philips Lighting health, we see professional healthcare and consumer health delivered strong LED sales growth and a significant converging. This provides a tremendous opportunity for increase in profitability, demonstrating the continued technology to play a role in data-enabled healthcare progress that the largest Lighting company in the industry delivery, also supporting the shift from hospital care and is making. In February 2017 we further reduced our stake acute reactive care to more proactive ambulatory and home in Philips Lighting’s issued and outstanding share capital care. to approximately 55%, in line with our stated aim to fully sell down our stake in Philips Lighting over the next several Through our market-leading propositions in Personal Health, years. Separately, in December we signed an agreement we have natural touchpoints with consumers to promote to sell the combined Lumileds and automotive Lighting healthy lifestyles, which are critical to good health. For businesses, effectively completing our portfolio example, our Dream Family is a comprehensive solution transformation. comprising sleep therapy devices, a comfortable mask, therapy management software and services to provide a I am pleased with the momentum in the overall business good night’s sleep for people with obstructive sleep apnea. performance of our HealthTech portfolio as our health And our connected Sonicare toothbrushes with smart sensor technology businesses posted 5% comparable sales technology help to improve oral healthcare through real- growth1) and a significant increase in profitability. At the time feedback and post-brush analytics. same time, we again stepped up our investments in quality, growth initiatives and innovation. In the hospital we are leading in integrated diagnostic solutions across various disciplines including radiology, Our solutions approach – where we combine suites of pathology and genomics, combining advanced imaging systems, smart devices, software and services to help our modalities and clinical decision support aided by artificial customers improve patient outcomes and productivity – intelligence and practice management software. continues to gain traction, as evidenced by 11% solutions revenue growth in the year and our winning 15 new long- We are leading in image-guided, minimally invasive term strategic partnerships around the world with an therapies which, compared with open surgery, have the aggregate value of approximately EUR 900 million. benefits of reduced patient trauma, shorter recovery times 4 This is the analyst selection from the Annual Report 2016 1) Non-GAAP financial measure. For the definition and reconciliation to the most directly comparable GAAP measure, refer to chapter 4, Reconciliation of non-GAAP information, of this Annual Report. Message from the CEO 1 and higher productivity. Our suites of interventional imaging are making progress in improving our customer excellence technologies and navigation software, combined with programs and in strengthening margins through productivity. interventional devices such as smart catheters, enable This is a continuation of our Accelerate! program, where there complex procedures in cardiology and oncology, for is considerable scope for ‘self-help’ by applying the Philips example. Our enterprise patient monitoring informatics Business System. We will drive higher productivity by solutions greatly reduce adverse events for patients and lowering the cost of goods, non-manufacturing cost and the lighten the workload for nurses. And we are increasing our cost of non-quality, while at the same time embedding the contribution to improve population health management with digital transformation in everything we do. Digitization is a data analytics and targeted programs to improve health great enabler of cutting-edge value propositions, as well as outcomes of patient cohorts with multiple co-morbidities driving higher levels of customer service, productivity and and to reduce costs.
Load more

Recommended publications
  • Digital Pathology: the Dutch Perspective
    Digital pathology: The Dutch perspective Paul J van Diest, MD, PhD Professor and Head, Department of Pathology University Medical Center Utrecht PO Box 85500, 3508 GA Utrecht The Netherlands [email protected] Professor of Oncology Johns Hopkins Oncology Center Baltimore, MD, USA Notice of Faculty Disclosure In accordance with ACCME guidelines, any individual in a position to influence and/or control the content of this ASCP CME activity has disclosed all relevant financial relationships within the past 12 months with commercial interests that provide products and/or services related to the content of this CME activity. The individual below has responded that he/she has no relevant financial relationship(s) with commercial interest(s) to disclose: Paul J. van Diest, MD, PhD Disclosures • member of advisory boards of Roche, Sectra, Philips (unpaid) • client of Hamamatsu, Sectra, Visiopharm, Leica, Aurora, Philips (paying heavily) • test scanners from Philips and Roche (no contract, no fee) • joint research projects with Philips UMCU Why The Netherlands? • “bunch-a-crazy dudes” • innovation is our middle name • not bound by too many rules and EU-FDA • strong believe in advantages in digital pathology Advantages of digital pathology • no more case assembly in the lab efficacy • quicker diagnostics efficacy • easy and more accurate measurements and counting patient safety/efficacy • better overview of tissue present patient safety • flagging missing slides patient safety • tracking viewing patient safety • automatic linking of images/reporting/LMS
    [Show full text]
  • Royal Philips First Quarter 2016 Results Information Booklet
    Royal Philips First Quarter 2016 Results Information booklet April 25th, 2016 1 Important information Forward-looking statements This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, domestic and global economic and business conditions, developments within the euro zone, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips’ actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements.
    [Show full text]
  • Philips 2017 Annual Report
    Investor Relations 15.1 In 2017, a dividend of EUR 0.80 per common share was Exchange rate (based on the “Noon Buying Rate”) EUR per USD paid in cash or shares, at the option of the shareholder. 2013 - 2017 For 48.3% of the shares, the shareholders elected for a period end average high low share dividend, resulting in the issue of 11,264,163 new 2013 0.7257 0.7532 0.7828 0.7238 common shares, leading to a 1.2% dilution. EUR 384 2014 0.8264 0.7533 0.8264 0.7180 million was paid in cash. See also section 3.5, Proposed 2015 0.9209 0.9018 0.9502 0.8323 distribution to shareholders, of this Annual Report. 2016 0.9477 0.9037 0.9639 0.8684 2017 0.8318 0.8867 0.9601 0.8305 ex-dividend date record date payment date Exchange rate per month (based on the “Noon Buying Euronext Rate”) EUR per USD Amsterdam May 7, 2018 May 8, 2018 June 6, 2018 2017 - 2018 New York highest rate lowest rate Stock Exchange May 7, 2018 May 8, 2018 June 6, 2018 August, 2017 0.8545 0.8316 September, 2017 0.8513 0.8305 October, 2017 0.8636 0.8441 Philips Group November, 2017 0.8638 0.8378 Dividend and dividend yield per common share 2008 - 2018 December, 2017 0.8529 0.8318 January, 2018 0.8388 0.8008 5.1% 4.6% 3.4% 3.3% 3.8% 3.3% 3.4% 2.4% 3.0% 2.8% 2.5% Yield in %1) Unless otherwise stated, for the convenience of the 2) 0.80 0.80 0.80 0.80 0.80 Dividend per reader, the translations of euros into US dollars 0.75 0.75 0.75 0.70 0.70 0.70 share in EUR appearing in this section have been made based on the closing rate on December 31, 2017 (USD 1 = EUR 0.8365).
    [Show full text]
  • Koninklijke Philips N.V
    Deutsche Bank CORPORATE BANK Depositary Receipts Announcement July 08, 2020 KONINKLIJKE PHILIPS N.V. Please be advised of the following Final DR Stock Distribution information: Depositary Receipt Information CUSIP: 500472303 Contacts Country: Netherlands American Stock Transfer Dividend Type: Stock Tel: +1 (800) 821-8780 Ord Record Date: 01-Jul-20 DR Record Date: 01-Jul-20 Email: [email protected] Ord Payable Date: 07-Jul-20 DR Payable Date: 07-Jul-20 Corporate Actions Ord: DR Ratio: 1 : 1 Web: www.adr.db.com Gwen Minott +1-212-250-6182 Tax Rate: 0.00% Distribution Rate: 2.028516% (1 for 49.2971) Cash in Lieu Rate: $48.2429 Issuance Fee: $0.00 Cash in Lieu Payment Date: 7/9/2020 Koninklijke Philips N.V. maintains its proposed dividend of EUR 0.85 (USD 0.954082) per common share against the net income of 2019. The distribution of this dividend is in shares only, instead of the previously proposed distribution in cash or in shares, as approved at the Extraordinary General Meeting of shareholders held on June 26, 2020. Dividend in shares paid out of net income is in principle subject to a 15% dividend withholding tax, but only in respect of the par value of the shares (which value amounts to EUR 0.20 per share). Shareholders are advised to consult their tax advisor on the applicable situation with respect to taxes on the dividend received. On July 2, 2020 after close of trading on Euronext Amsterdam,the number of share dividend rights entitled to one new common share was determined based on the volume-weighted average price of all traded common shares Koninklijke Philips N.V.
    [Show full text]
  • Information Regarding Optional Dividend - Koninklijke Philips N.V
    Information Regarding Optional Dividend - Koninklijke Philips N.V. (Royal Philips) The General Meeting of Shareholders approved the distribution of EUR 0.85 per common share, at its annual meeting held on May 9, 2019. The distribution will be payable in cash or shares, at the option of the shareholder, against the net income for 2018. The company will calculate the number of share dividend rights entitled to one new common share, such that the gross dividend in shares will be approximately equal to the gross dividend in cash. Dividend in cash is in principle subject to 15% Dutch dividend withholding tax, which will be deducted from the dividend in cash paid to the shareholders. Dividend in shares paid out of net income and retained earnings is in principle subject to 15% dividend withholding tax, but only in respect of the par value of the shares (which value amounts to EUR 0.20 per share). By distributing an optional dividend, the company allows its shareholders to choose between receiving cash or shares. You are given the opportunity as of Wednesday, May 15, 2019, until: (1) Thursday June 6, 2019 (10.00 a.m. EST) if you are a holder of New York Registry Shares traded on the New York Stock Exchange; and (2) Friday June 7, 2019 (03.00 p.m. CET) if you are a holder of shares that are traded on the stock market of Euronext Amsterdam or a holder of registered shares included in the company’s shareholders register, to indicate your choice between cash and shares. If no choice is made during this election period the dividend will be paid in cash.
    [Show full text]
  • Kickstart AI Consortium Members, Ahold Delhaize and Philips, Announce New Round of Academic Joint Appointments
    Kickstart AI consortium members, Ahold Delhaize and Philips, announce new round of academic joint appointments Zaandam, the Netherlands, July 1, 2020 – Today Ahold Delhaize and Philips announced two new joint appointments as part of their continuing commitment to the Kickstart AI platform, announced in October 2019. These appointments are established to strengthen AI research and education capabilities and to train the next generation of AI researchers in the Netherlands. Ahold Delhaize welcomes Maarten de Rijke, Ph.D., currently University Professor of Artificial Intelligence and Information Retrieval at the University of Amsterdam, while Ruud van Sloun, Assistant Professor at the Eindhoven University of Technology, joins Philips. Additionally, ING opened two positions together with the University of Amsterdam. The Kickstart AI member companies have committed to establishing joint positions of academic staff to enable private-public collaboration and facilitate researchers’ work in both industry and university settings. Job creation, retention of AI talent, and fostering shared AI knowledge are at the key drivers of the Kickstart AI initiative and recognized as essential elements in supporting economic recovery in the coming years. Maarten de Rijke’s work with Ahold Delhaize will focus on building intelligent technology to connect people to information. Such solutions include search engines, recommender systems, and conversational assistants. Dr. De Rijke’s research focuses on the intersection of information retrieval and machine learning, where increasingly intelligent machines learn from interactions with users. De Rijke is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW) and a strong believer in use- inspired research, mixing theory, experimentation, and application.
    [Show full text]
  • Koninklijke Philips N.V
    Koninklijke Philips N.V. High Tech Campus 5, 5656 AE Eindhoven, the Netherlands INFORMATION REGARDING OPTIONAL DIVIDEND - KONINKLIJKE PHILIPS N.V. (Royal Philips) The Annual General Meeting of Shareholders held on May 1, 2014 has approved the payment of a distribution of EUR 0.80 per common share of EUR 0.20 par value. The distribution will be payable in cash or shares, at the option of the shareholder, against the net income for 2013 of the Company. The Company will calculate the number of share dividend rights entitled to one new common share, such that the gross dividend in shares will be approximately equal to the gross dividend in cash. Dividend in cash is in principle subject to 15% Dutch dividend withholding tax, which will be _ deducted from the dividend in cash paid to the shareholders. Dividend in shares paid out of earnings is subject to 15% dividend withholding tax, but only in respect of the par value of the shares (which value amounts to EUR 0.20 per share). You are given the opportunity until the close of NYSE Euronext Amsterdam N.V. ("Euronext Amsterdam") on Friday, May 30, 2014 (15.00h CET) to indicate your _ choice. On Tuesday, June 3, 2014, the number of share dividend rights of the common shares entitling to one new share (“exchange ratio”), as well as the dividend withholding tax being withheld over the nominal value per new share, will be published. _ This exchange ratio is based on the volume weighted average price of all traded common shares Koninklijke Philips N.V.
    [Show full text]
  • Anton Philips (1874 - 1951)
    Anton Philips (1874 - 1951) They will know who they're dealing with © Marcel Metze Balans Publishers, Amsterdam, 2004, isbn 90 5018 612 2 Summary In January 1895 young Anton Philips travelled to Eindhoven, a small town in the southern part of The Netherlands. His brother Gerard had a little factory there for the production of electric light bulbs and needed a sales-assistant. He was twenty and expected to spend half a year in Eindhoven, at the most. Things turned out differently. As a trade school student he had been a failure but he did like the practice of selling and buying. So he decided to stay. Anton was gifted with natural charm, a negotiating talent, energy and confidence. He had courage: In 1898, just twenty-four years old and hardly speaking any foreign languages, he took a train to Russia and returned with huge orders. He became a formidable salesman: in 1912, he started a joint venture in the USA and in a couple of years reached 10 percent of General Electric's sales numbers, making this giant fear that he would eventually threaten its dominant market position. He had an excellent nose for business opportunities. When World War One broke out in 1914, the Russians wouldn't buy German lamps anymore. Anton immediately sent one of his salesmen to St. Petersburg. His speed of action was unparalleled. When the war ended in November 1918 and British forces re-captured Brussels, he was right behind them to start Philips' first foreign sales subsidiary. It took the Philips Incandescent Light Works (NV Philips' Gloeilampenfabrieken), officially founded in 1891, four decades to reach the top of the lighting industry.
    [Show full text]
  • ECORFAN Journal-Mexico NET BUSINESS Financial Innovations
    510 Article ECORFAN Journal-Mexico NET BUSINESS April 2012 Vol.3 No.6 510-521 Financial innovations: Role of CDOs, CDS and securitization during the US financial crisis 2007-2009 AZIZ- Bilal ´⃰ University of Punjab Lahore: 54590 Punjab: Pakistán. Received October 11, 2011; Accepted March 28, 2012 This Paper seeks to explain the role of Financial Innovations behind the Financial Crisis 2007-2009 with a special focus on the Collateralized Debt Obligations, Credit Default Swaps and Securitization, there role in US Financial System and how these factors generated and worsen the crisis. Financial Crisis 2007-2009 which starts from the United States sub-prime Mortgage market and spread to US financial sector and later on spread to the rest of world is said to be the even bigger crisis than the Great Depression of 1929. This crisis is unique in this way that in history we haven’t seen such a bigger impact world wide from any crisis. This paper would analyze the main causes which are right in the heart of the crisis and least discussed. Credit default swaps, securitization , collateralized debt obligation, derivatives ,mortgage Back Securities(MBS). Citation: Aziz B. Financial innovations: Role of CDOs, CDS and securitization during the US financial crisis 2007-2009. ECORFAN Journal-Mexico 2012, 3-6: 510-521 ⃰ Correspondence to Author (email:[email protected]) † Researcher contributing first author. © ECORFAN Journal-Mexico www.ecorfan.org 511 Article ECORFAN Journal-Mexico NET BUSINESS April 2012 Vol.3 No.6 510-521 Introduction Some of them were so complex that it creates mess in the market.
    [Show full text]
  • Space for Ambitions the Dutch Space Program in Changing European and Transatlantic Contexts D.M
    Space for ambitions the Dutch space program in changing European and transatlantic contexts D.M. Baneke Abstract: Why would a small country like the Netherlands become active in space? The field was monopolized by large countries with large military establishments, especially in the early years of spaceflight. Nevertheless, the Netherlands established a space program in the late 1960s. In this paper I will analyze the backgrounds of Dutch space policy in international post- war politics, national industrial policy, and science. After the Second World War, European space activities were shaped by the interplay between transatlantic and European cooperation and competition, limited by American Cold War diplomacy. At the national level the Dutch space program was shaped firstly by two powerful companies, Philips electronics and Fokker Aircraft. As I will demonstrate, these two firms sought to gain crucial management skills as well as technological ones. Meanwhile, the nation's astronomers were able to capitalize on an advantageous confluence of political, economic and scientific ambitions to forward their own agenda. They succeeded in obtaining two of the most expensive scientific instruments ever built in the Netherlands: the Astronomical Netherlands Satellite (ANS, launched 1974) and the Infrared Astronomical Satellite (IRAS, 1983). Both were joint Dutch-American missions, but the nature of the cooperation on each was very different, reflecting the changing relationship between America and Western Europe from the 1950s until the 1980s. In 1965, the Dutch astronomical community received a letter from the Ministry of Education and Sciences. The government had decided to fund the construction of a satellite; would the astronomers have any use for it? The result, launched in 1974, was the Astronomical Netherlands Satellite (ANS).
    [Show full text]
  • Northern Netherlands, Region of Smart Factories.Pdf
    Region of Smart Factories RIM plus 29th april 2015 Hans Praat Investment and Development Agency for the Northern Netherlands [email protected] ContentContent • Industry 4.0 • Dutch Smart Industry programme • Northern Netherlands: Region of Smart Factory – Business case Philips – Business case Fokker The changing face of industry and society Source: http://www.smartindustry.nl/ Enabled by new, converging technologies • Internet of Things • adaptive robots • 3D printing • embedded systems • smart grid technologies • man-machine interfaces • Cyber Physical Systems • advanced sensors • big data and cloud computing • zero defect manufacturing. Source: http://www.smartindustry.nl/ In very short Enablers Results Customization Digitalization Disruptive business models Scientification Break through in development & Internet of Things manufacturing Smart products Smart Factories Zero Defect First time Right product Smart Factory manufacturing + & process development = • Stabilizing everything • Emperical studies • planning-based • Risk avoiding • Standardized products • Trial & error • Selling ‘no’ - proto/0-series/series - years of optimization Turbulence, complexity and competition Model ling Big Digitalization Modelbased design Data ICT • Autonomous and self- • Kwowledge -> algorithems Hard learning manufacturing • Modeling & simulation ware • Smart connections • Integrated models Connectivity in Smart Industry OEM OEM suppy man chain machine machine customers machine product machine Suppy chain Factory Market Zero defect: the only way to the customer oriented business operations • Personalized products? • Lot size 1? Max flex? Then don’t forget to • More functionality? create your Smart • Smoothly teaming up with your Factory first suppliers? • Save budget for research & market development? • Less problem solving Resource efficiency • No need for constant Cost reduction 50%? adjustments • No effort in conditioning Productivity 2x? input / throughput Delete barriers for customization parameters, etc.
    [Show full text]
  • Philips Annual Report 2004 1 Contents
    Annual Report 2004 A new approach to annual reporting Forward-looking statements Philips is striving to combine timely reporting of its annual financial This document contains certain forward-looking statements with respect to the financial results with full disclosure and transparency. condition, results of operations and business of Philips and certain of the plans and This year, Philips has again accelerated the reporting of its annual objectives of Philips with respect to these items (including, but not limited to, cost financial results. The performance in 2004 has been summarized in savings), in particular the outlook paragraph of the Operating and financial review and a separate booklet entitled ‘Annual Review 2004’ of Koninklijke prospects in this Annual Report booklet. Philips Electronics N.V. (‘Royal Philips Electronics’, or the By their nature, forward-looking statements involve risk and uncertainty because they ‘Company’), which was published on January 27, 2005. relate to events and depend on circumstances that will occur in the future. There are a Full financial information and further statutory and other number of factors that could cause actual results and developments to differ materially information, including the Operating and financial review and from those expressed or implied by these forward-looking statements. These factors prospects, is contained in this Annual Report. include, but are not limited to, levels of consumer and business spending in major economies, changes in consumer tastes and preferences, changes
    [Show full text]